Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 724.00
Bid: 722.00
Ask: 726.00
Change: 6.00 (0.84%)
Spread: 4.00 (0.554%)
Open: 722.00
High: 724.00
Low: 720.00
Prev. Close: 718.00
JCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change to Risk Management Limits

11 Jun 2021 11:28

RNS Number : 6583B
JPMorgan Claverhouse IT PLC
11 June 2021
 

 

JPMorgan Claverhouse IT PLC

11 June 2021

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company')

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

 

 

Change to Risk Management Limits

 

The Company invests a diversified portfolio seeking capital and income growth from UK companies. It has a strong dividend track record, with 48 consecutive years of dividend growth. Investment Managers, William Meadon and Callum Abbot, follow an active, best ideas approach to constructing a diversified portfolio which consists typically of between 60 and 80 investments.

 

As disclosed in the Company's Annual Report, the Board has previously agreed certain guidelines with the Investment Managers to seek to manage risk relative to the Company's benchmark index by limiting the active portfolio exposure to individual sectors and stocks.

 

Over time, the current risk limits have increasingly impacted the Investment Managers' ability to invest in their best ideas. This has become particularly acute following the changes in March 2021 to the industry classification benchmark. Stocks that were previously spread across a number of sectors moved into a new sector. As a result, whilst the portfolio positioning had not changed, the positions were close to breaching sector limits.

 

Following a review, the Board has concluded that the Investment Managers' active approach is a key feature of the Company, and that risk can be managed effectively at a portfolio level. It therefore has agreed to amend certain of the risk limits, bringing the Company in-line with internal and external peers:

 

· Stock limits for overweight positions will remain unchanged. However, the Investment Managers will be permitted to operate a "do not like do not hold" approach for underweight positions (previously limited to -3%). This is expected to affect only a small number of stocks. The significant majority of the c.600 stocks in the FTSE All Share Index have small index weights; therefore the Investment Managers' ability to have large underweight positions is limited to their small index weight. There are currently nine stocks with an index weight over 2% and five stocks with an index weight over 3%. The risk implications of any large underweight will always be considered within the context of the broader portfolio; and

 

· Sector exposures will in future deviate from any index weighting by a maximum of 10% (previously limited to +/-5%). In the Investment Managers' view, risks such as macro or theme risk can be managed at the portfolio level and therefore whilst the current sector risk limits do not add to risk mitigation they do restrict the Investment Managers' ability to invest in their best ideas.

 

A comparison of the existing risk guidelines and the new guidelines are set out in the Appendix, below.

 

Katie Standley 0207 134 6220

Nira Mistry 0207 742 4000

JPMorgan Funds Limited

Company Secretary

 

APPENDIX

Comparison of risk guidelines

 

 

Existing

New

Market cap

Total exposure to small cap companies will normally range between +/-5% of the FTSE Small Cap Index weighting within the FTSE All-Share Index

Unchanged

Sector

Maximum exposure of +/-5% relative to benchmark index. Target sector active limits of up to +/- 3%

Maximum exposure of +/-10% relative to benchmark index. Target sector active limits of up to +/- 8%

Stock

 

 

Overweight

Maximum exposure of +3% relative to its weight in the benchmark index

Unchanged

Underweight

Maximum exposure of -3% relative to its weight in the benchmark index

 

No requirement to hold stocks the Investment Managers do not wish to invest in. Risk implications of any large underweight will always be considered within the context of the broader portfolio

Non benchmark exposure

Maximum of 5% of the assets may be invested in companies outside the benchmark index

Unchanged

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFBMMTMTTBBIB
Date   Source Headline
3rd May 202410:56 amRNSNet Asset Value(s)
2nd May 202411:19 amRNSNet Asset Value(s)
1st May 202411:49 amRNSTotal Voting Rights
1st May 202411:23 amRNSNet Asset Value(s)
30th Apr 202411:06 amRNSNet Asset Value(s)
29th Apr 20245:18 pmRNSResult of AGM
29th Apr 202412:01 pmRNSGearing Announcement
29th Apr 202411:04 amRNSNet Asset Value(s)
26th Apr 202410:47 amRNSNet Asset Value(s)
25th Apr 20245:03 pmRNSTransaction in Own Shares
25th Apr 202410:08 amRNSNet Asset Value(s)
24th Apr 202410:19 amRNSNet Asset Value(s)
23rd Apr 202410:31 amRNSNet Asset Value(s)
22nd Apr 202411:20 amRNSGearing announcement
22nd Apr 202410:48 amRNSNet Asset Value(s)
19th Apr 202410:26 amRNSNet Asset Value(s)
18th Apr 202410:52 amRNSNet Asset Value(s)
17th Apr 202410:43 amRNSNet Asset Value(s)
17th Apr 20247:00 amRNSDividend Declaration
16th Apr 202410:30 amRNSNet Asset Value(s)
15th Apr 20244:48 pmRNSTransaction in Own Shares
15th Apr 202411:39 amRNSGearing Anouncement
15th Apr 202410:33 amRNSNet Asset Value(s)
12th Apr 202410:59 amRNSNet Asset Value(s)
11th Apr 20243:24 pmRNSTen Largest Investments
11th Apr 202410:46 amRNSNet Asset Value(s)
10th Apr 202411:49 amRNSNet Asset Value(s)
9th Apr 202410:35 amRNSNet Asset Value(s)
8th Apr 20245:09 pmRNSTransaction in Own Shares
8th Apr 202411:56 amRNSGearing Announcement
8th Apr 202410:31 amRNSNet Asset Value(s)
5th Apr 202410:40 amRNSNet Asset Value(s)
4th Apr 20244:57 pmRNSTransaction in Own Shares
4th Apr 202410:40 amRNSNet Asset Value(s)
3rd Apr 20245:03 pmRNSTransaction in Own Shares
3rd Apr 202411:36 amRNSNet Asset Value(s)
2nd Apr 20242:45 pmRNSGearing Announcement
2nd Apr 20241:40 pmRNSNet Asset Value(s)
2nd Apr 202411:28 amRNSTotal Voting Rights
28th Mar 202410:25 amRNSNet Asset Value(s)
27th Mar 20245:44 pmRNSTransaction in Own Shares
27th Mar 202410:53 amRNSNet Asset Value(s)
26th Mar 20245:33 pmRNSTransaction in Own Shares
26th Mar 202410:43 amRNSNet Asset Value(s)
25th Mar 202412:37 pmRNSGearing Announcement
25th Mar 202411:02 amRNSNet Asset Value(s)
22nd Mar 20245:11 pmRNSTransaction in Own Shares
22nd Mar 202411:10 amRNSNet Asset Value(s)
21st Mar 202410:42 amRNSNet Asset Value(s)
21st Mar 20247:00 amRNSFINAL RESULTS FOR YEAR TO 31 DEC 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.